India's pharma sector evolves with Biopharma SHAKTI Scheme, focusing on biologics, biosimilars, and advanced therapies to boost global competitiveness and healthcare.

India’s pharmaceutical industry is shaping global healthcare, and women leaders are playing a decisive role in that growth. This Women’s Day 2026 feature highlights ten influential women leading strategy, innovation, and expansion across India’s phar

Complex generics and biosimilars are reshaping global pharma. As patents expire and demand rises, 2026 marks a turning point for innovation, competition, and access.

Pharma companies delivered mixed Q3 FY26 numbers as earnings hit markets. Some firms posted strong revenue and profit growth while others faced margin pressure. Investors reacted fast, with stocks rising or dipping based on results and outlooks.

The new wave of Nipah virus in India has once again placed the pharma industry in the limelight and why their involvement is more important than ever. In West Bengal, authorities confirmed two Nipah cases since December 2025, with extensive...

India’s biotech sector is moving into a phase where execution matters more than ambition. In 2026, the leaders to watch are those managing scale, pressure, and responsibility. This list highlights ten innovators shaping how science, medicine...